Recent studies have confirmed that BBR can significantly downregulate the expression of CRC metastasis-related proteins E-cadherin, β-catenin, and cyclin D1 during MET, playing a positive role in preventing CRC cells from metastasizing to the lung and liver (Ni et al., 2022). Here, CCND1 is linked to colorectal carcinoma.